NEW YORK (GenomeWeb News) – Sequenom said today that it has licensed from Xenomics intellectual property for use in prenatal research and diagnostic tests.
 
The exclusive license gives Sequenom global rights to use certain transrenal fetal nucleic acids in maternal urine for non-invasive prenatal diagnostics and analysis. The technology may be used on a technology-independent basis for “all uses,” excluding the determination of fetal gender solely by the presence of Y chromosome, Sequenom said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.